Clinical Trials · NCT02119884
Hemodynamic Effects of Terlipressin and High Dose Octreotide
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- Shanghai Zhongshan Hospital
- Enrollment
- 88
- Start date
- Feb 2014
- Locations
- 1 site, China
- Primary endpoint
- Fluctuation of HVPG